You are searching for: hsa04072

---

T64969 Target Info	Target Name	Epidermal growth factor receptor variant III (EGFR vIII)
	Target type	Clinical trial Target
	Disease	Brain cancer; Malignant glioma;
	Drugs	Anti-EGFRvIII CAR transduced PBL	Drug Info

T48598 Target Info	Target Name	GTPase KRas (KRAS)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	AZD4785	Drug Info

T88451 Target Info	Target Name	Mutated tyrosine-protein kinase Kit (mKIT)
	Target type	Literature-reported Target
	Disease	Not Available
	Drugs	Not Available

T87350 Target Info	Target Name	Platelet-derived growth factor B (PDGFB)
	Target type	Clinical trial Target
	Disease	Diabetic foot ulcer; Macular degeneration;
	Drugs	PDGF-BB	Drug Info

T95923 Target Info	Target Name	Lysophosphatidate-3 receptor (LPAR3)
	Target type	Clinical trial Target
	Disease	Fibrosis; Systemic sclerosis;
	Drugs	SAR-100842	Drug Info

T10383 Target Info	Target Name	Phospholipase D2 (PLD2)
	Target type	Clinical trial Target
	Disease	Coagulation defect;
	Drugs	VU0364739	Drug Info

T06869 Target Info	Target Name	Platelet-derived growth factor A (PDGFA)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; Diabetic macular edema;
	Drugs	Squalamine	Drug Info

T03046 Target Info	Target Name	Mutated KRAS (mKRAS)
	Target type	Clinical trial Target
	Disease	Pancreatic cancer;
	Drugs	GI-4000 + gemcitabine	Drug Info

T16538 Target Info	Target Name	EGFR T790M mutant (EGFR T790M)
	Target type	Successful Target
	Disease	Non-small-cell lung cancer; Melanoma;
	Drugs	Osimertinib	Drug Info

T27137 Target Info	Target Name	Metabotropic glutamate receptor 1 (mGluR1)
	Target type	Discontinued Target
	Disease	Alzheimer disease; Schizophrenia;
	Drugs	PF-1913539	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.